BMT as initial treatment for severe aplastic anemia, macrophage metabolic rewiring in sickle cell disease, and predicting outcomes using PET radiomics in diffuse large B cell lymphoma
Blood Podcast
00:00
The Effect of Cyclophosphamide on the Outcomes of BMT in Patients With Severe Aplastic Anemia
The study included 20 patients with either acquired or inherited SAA enrolled on the trial between August 2016 and July 2020. Cyclophosphamide was given as post-transplantation graft versus host prophylaxis. The overall survival for 27 treated patients was 92 percent at one, two, and three years post-treatment.
Transcript
Play full episode
